UAE Approves MIEBO, Innovative Dry Eye Treatment

May 16, 2026

54 min

May 16, 2026 08:30

UAE world's 3rd country to approve MIEBO, innovative treatment for dry eye

## UAE's Milestone in Eye Care

The United Arab Emirates has become the third country globally to approve MIEBO, a groundbreaking prescription eye drop designed to treat dry eye disease. This approval by the Emirates Drug Establishment marks a significant step in enhancing access to advanced eye care solutions in the region.

## How MIEBO Works

MIEBO, developed by Bausch + Lomb, is the first eye drop that directly addresses tear evaporation, a primary cause of dry eye disease. The active ingredient, perfluorohexyloctane, helps stabilize the tear film and alleviate symptoms, offering relief to those affected by this common condition.

## Clinical Success

The approval follows positive outcomes from two clinical trials, GOBI and MOJAVE, which involved over 1,200 participants. These studies demonstrated significant improvements in both the signs and symptoms of dry eye disease, supporting MIEBO's effectiveness.

## Addressing a Global Health Issue

Dry eye disease affects millions worldwide, impacting visual comfort and quality of life. The introduction of MIEBO in the UAE aligns with the country's commitment to adopting cutting-edge therapeutic technologies and improving healthcare standards.

Read the full story at the source

What you need to know to get Emirates ID?

Leave your details and get a guide as a gift to avoid mistakes

Article contents